Nantahala Capital Management, LLC Fulcrum Therapeutics, Inc. Transaction History
Nantahala Capital Management, LLC
- $1.99 Billion
- Q4 2024
A detailed history of Nantahala Capital Management, LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 4,779,708 shares of FULC stock, worth $18 Million. This represents 1.13% of its overall portfolio holdings.
Number of Shares
4,779,708
Previous 4,777,912
0.04%
Holding current value
$18 Million
Previous $17.1 Million
31.7%
% of portfolio
1.13%
Previous 1.01%
Shares
4 transactions
Others Institutions Holding FULC
# of Institutions
130Shares Held
51.6MCall Options Held
1.04MPut Options Held
32.6K-
Ra Capital Management, L.P. Boston, MA10.2MShares$38.6 Million0.78% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$19.8 Million4.03% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$18.1 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.34MShares$12.6 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.25MShares$12.3 Million0.0% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $196M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...